Smoking Cessation And Nicotine De-Addiction Market was valued at over USD 7.0 billion in 2015 And Is Expected Reach $21.8 Billion By 2024: Grand View Research, Inc.

The global smoking cessation and nicotine de-addiction market is expected to reach over USD 21.8 billion by 2024 according to a new report by Grand View Research, Inc.
The base of population addicted to smoking is rapidly increasing across the globe. This population subset majorly includes teenagers and the working population. Smoking-related mortality is very high. The increasing desire to quit smoking and the numerous health complications associated with smoking serve as strong incentives for companies to introduce novel smoking cessation products, such as Revolymer, which has introduced the next generation nicotine gums to help smokers quit smoking. The launch of these improved and innovative nicotine replacement therapy products is to serve as a high impact rendering driver for the growth of the smoking cessation and nicotine de-addiction market.
The growing incidence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing awareness pertaining to the hazardous side-effects of smoking are the factors expected to promote market expansion. Educational institutions remain active in organizing various campaigns and programs to spread information about the harmful effects and consequences of smoking so as to increase young population awareness.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/smoking-cessation-and-nicotine-de-addiction-products-market

Further key findings from the study suggest:

·         Nicotine Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine addiction product market in 2015. Majorly used NRT products include nicotine chewing gums and the transdermal patches. Increased availability and the introduction of the ingestible nicotine products with different flavors are the factors responsible for its large market share.

·         The e-cigarette segment is anticipated to grow at a CAGR of19.0% over the forecast period. The major factors responsible for the growth of the E-cigarette market include the introduction of second and third generation e-cigarettes, the availability of various flavored products, the presence of numerous vendors operating and selling e-cigarettes under different brand names.

·         North America held a large market share of over 35.0% in 2015 owing to the high awareness levels of nicotine de-addiction products with around 90% of the U.S. population were identified as aware of e-cigarettes in 2015

·         Asia Pacific is the fastest growing market. The registration of nicotine de-addiction products and e-cigarettes as well as the strengthening of the company distribution channels in countries, such as China, India, and Australia are expected to support the growth over the forecast period

·         Some key players of this market are Pfizer, Inc., Cipla Ltd., Novartis International AG, GlaxoSmithKline plc, Takeda pharmaceutical Company Ltd., McNeil AB, Revolymer plc, Imperial Tobacco Ltd., and VMR products, LLC

·         The market players are making slow but steady progress in the e-cigarette market by focusing on the development, commercialization, and distribution of the FDA approved nicotine products. For instance, in 2014, Victory Electronic Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand their distribution channels and attain wider market coverage.

Read detailed report or request for sample of this research report: - http://www.grandviewresearch.com/industry-analysis/smoking-cessation-and-nicotine-de-addiction-products-market/request

Grand View Research has segmented the smoking cessation and nicotine de-addiction market on the basis of product and region.
Global Smoking Cessation and Nicotine De-addiction Market Product Outlook, by Revenue (USD Million, 2015 – 2024)

·         Nicotine Replacement Therapy 

·         Nicotine Spray

·         Nicotine Inhalers

·         Nicotine Gum

·         Nicotine Transdermal Patches

·         Nicotine Sublingual Tablets

·         Nicotine Lozenges

·         Drug Therapy

·         Varenicline

·         Zyban

·         Nicorette Buccal

·         E-cigarettes

Smoking Cessation and Nicotine De-addiction Market Regional Outlook, by Revenue (USD Million, 2015 – 2024)

·         North America

·         U.S.

·         Canada

·         Europe

·         UK

·         Germany

·         Asia Pacific

·         Japan

·         China

·         Latin America

·          Brazil

·         MEA

·         South Africa

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals

CIS Insulin Market Will Grow Rapidly Owing To Rising Demand For Fast Food Industry Till 2024

The CIS Insulin Market is expected to reach USD 3,008.5 million by 2020 growing at a CAGR of 15.0%, according to a new study by Grand View Research, Inc. The presence of an extensive pipeline portfolio of products exhibiting higher efficacies and their subsequent commercialization over the next six years is expected to serve this market as a high impact rendering driver. The introduction of government initiatives aimed at improving the affordability of insulin via price reduction, such as the collaboration between the government of Ukraine and Indar to reduce the price of insulin by 20% in 2013 is expected to have positive influence on demand. Some of the other drivers of this market include increasing attempts made by manufacturers to capitalize on the untapped opportunities by opening new manufacturing units to improve the supply of insulin and growing incidence rates of type II diabetes are some of the factors expected to fuel future market growth.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/cis-insulin-market

Further key findings from the study suggest:

• Regionally, Russia occupied the largest share of the market, accounting for 69.2% of the revenue. Its large share is majorly attributed by the subsidies that Russian government provides to make insulin more affordable for patients.

• Ukraine is expected to register the fastest CAGR of 15.6% during the forecast period due to the presence of high untapped opportunities and encouraging government initiatives.

• In addition, Poland is expected to grow at a lucrative rate during the forecast period majorly owing to the presence of high diabetes prevalence coupled with increasing healthcare expenditures.

• Long acting insulin accounted for the largest share of the market, at over 39.0% in 2013, owing to the higher preference given to long acting insulin therapy for diabetes which results in lesser episodes of low blood sugar. It is also expected that this product segment will grow at the fastest CAGR of over 18.0% during the next six years.

• Application of insulin for control of type II diabetes occupied for over 90.0% of the market owing to the presence of larger portfolio of products catering to this segment and a relatively larger prevalence base

• Analogs accounted for over 80.0% of the revenue owing to their relatively higher prices and better efficacy levels. In addition, this segment is expected to exhibit the fastest CAGR during the forecast period on account of the introduction of technologically advanced products such as ultra-long and ultra-fast acting analogs.

Read detailed report or request for sample of this research report: - http://www.grandviewresearch.com/industry-analysis/cis-insulin-market/request

For the purpose of this study, Grand View Research has segmented the CIS Insulin market on the basis of product, application, source and region:
CIS Insulin Product Outlook
            • Rapid Acting
            • Long Acting
            • Premixed
            • Premixed Analog
            • Short Acting
            • Intermediate Acting
CIS Insulin Application Outlook
            • Type II Diabetes
            • Type I Diabetes
CIS Insulin Source Outlook
            • Human Recombinant
            • Analogs
CIS Insulin Regional Outlook
            • Russia
            • Poland
            • Turkey
            • Ukraine
            • Uzbekistan
            • Belarus
            • Kazakhstan
            • Rest of CIS

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals

Chemoinformatics Market Is Expected To Witness Growth At 18.3% CAGR In Asia Pacific From 2016 To 2024: Grand View Research, Inc.

The global chemoinformatics market is expected to reach over USD 21.18 billion by 2024 according to a new report published by Grand View Research, Inc. Some major determinants influencing the market growth include the constantly improving modern drug development processes, increasing use of in-silico techniques in research, and the advantages associated with employing the chemoinformatics approach, such as the reduction in the overall R&D expenditure during the drug development process.
The ever increasing growth of the drug development market will boost the demand for chemoinformatics owing to its numerous applications in drug designing at various stages. Right from target identification to its development as a potential drug candidate, chemoinformatics tools play a crucial part.
The significant contributions of the varying in silico tools in the generation of hits through the High Throughput Screening(HTS) process, target compound selection, virtual structure generation, Pharmacokinetic property and toxicity prediction of chemical compounds, and the quantitative-structure relationship determination have been a major driving force for the growth of the chemoinformatics market.
The heavy costs incurred along with the long time span invested in the drug discovery process has made the integration of the chemoinformatics techniques essential in the research activities. It aids the scientists and chemical researchers in making better decisions pertaining to drug discovery and other related research studies. Furthermore, the increasing demand for efficient and effective medicines, rising investments in R&D, growing geriatric population, and the burgeoning number of individuals with lifestyle related diseases are expected to positively reinforce the market growth. The key applications of the chemoinformatics tools and softwares in drug designing and discovery has been its largest application and is expected to grow further with further advances in the drug discovery process.
Chemoinformatics has made marked contributions to the areas of chemical drug development and research. The growth of this field is driven by the continually generated raw data in screening operations and research studies. Chemoinformatics in silico tools aid in effective data management, which facilitate data retrieval and analysis thus providing large databases of accessible information to scientists involved in both, the drug development process and other research related studies.
The development of three dimensional chemical structure databases has been a significant achievement in the field of chemoinformatics as it has significantly aided the research process. Applications of chemoinformatics platforms in computer-assisted synthesis designing, computer-assisted structure elucidation, and chemometrics have further contributed to the market growth.
The advancements in computational technology have been a high impact rendering driver for the market growth. In this direction, the development of super computers and silicon graphics computer for calculations, 3D structure generation, molecular graphics, and complex data display have been pivotal in propelling the growth of the chemoinformatics market. With the advent of advanced WEB technologies and their incorporation in the in-silico computational techniques have totally revolutionized this field.
The increasing needs for advanced and efficient technologies to yield better results has made the chemoinformatics area an indispensable part of the pharmaceutical industry. The surging need for therapeutically-effective medicines coupled with the increasing investments in the R&D area and the advancements in computer technologies provide lucrative opportunities to the market for it to grow and flourish in the near future.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/chemoinformatics-market

Further key findings from the study suggest:

·         In 2015, North America dominated the chemoinformatics market with a revenue share of over 36% on account of the following factors:  the high investments pertaining to the R&D initiatives, technological advancements, the presence of major players in the drug manufacturing industry, and the increasing prevalence of lifestyle-related diseases. With respect to the global R&D spending, North America holds the largest share. Also, it holds a major share in the ADME-toxicology market that further spurs the growth of the chemoinformatics market.

·         Asia Pacific is identified as one of the fastest growing regional markets, growing at a lucrative CAGR of 18.3% during the forecast period. The growth of this market can be attributed to the growing research activities being conducted in economies, such as India, China, and Singapore. The key advantages associated with undertaking research activities in these countries include the low manufacturing and labor costs and the less stringent regulations, which attract many multinational players to the Asia Pacific region. Additionally, the government initiatives and funds that are deployed to improve the R&D infrastructure will further drive the market growth.

·         Key players operating in the market include Agilent Technologies, Inc., BIOVIA (Accelrys), Bio-Rad Laboratories, Inc., CambridgeSoft Corp., ChemAxon, Inc., ACD/Labs, Inc., Schrödinger, LLC, and Chemical Computing Group, Inc. Additionally, the rising demand for in-silico techniques in the research sector is expected to provide new market entrants with profitable opportunities thereby driving the market growth.

Read detailed report or request for sample of this research report: - http://www.grandviewresearch.com/industry-analysis/chemoinformatics-market/request

Grand View Research has segmented the chemoinformatics market by applications:
Global Chemoinformatics Market, by Application (USD Billion, 2016 - 2024)

·         Chemical Analysis

·         Drug Discovery

·         Drug Validation

·         Others

Chemoinformatics Market Regional Outlook, by Revenue (USD Billion, 2016 - 2024)

·         North America

·         U.S.

·         Canada

·         Europe

·         Germany

·         UK

·         Asia Pacific

·         Japan

·         China

·         India

·         Latin America

·         Brazil

·         Mexico

·         MEA

·         South Africa

 
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare-it

Breath Analyzer Market Will Witness Growth Based On Rising Demand For Efficient As Well As Accurate Alcohol And Narcotic Content Detectors Till 2024

The global Breath Analyzer Market is expected to reach USD 11.3 billion by 2024, according to a new report by Grand View Research, Inc. Major drivers of the market include the demand for breath analyzers arising from the law enforcement agencies as well as other institutions, such as schools, sports, and offices, to minimize alcohol abuse and ensure safety in workplace settings.
The fuel cell technology has been widely used in professional breath analyzers as it offers accuracy, alcohol specificity, and portability. Moreover, the semiconductor sensor technology offers affordable breath alcohol screening devices that are mostly used by private consumers. Breath analyzers that use infrared spectroscopy are currently limited to the law enforcement agencies owing to their high cost and large device size.
The growing demand for quick and easy methods for the primary diagnosis of diseases, such as asthma, chronic obstructive pulmonary disease, and cancer is augmenting the growth of the global market. In addition, the rising adoption of breath analyzers in smoking cessation programs to detect carbon monoxide in the exhaled air is augmenting the market growth.
Uncertainty with regard to the accuracy of the devices, the ambiguous laws about installing these devices in offices, and the high prices attached to infrared spectroscopy are the factors that challenge the growth of the global market. Many of the drug detection devices that identify the presence of drugs in the exhaled breath are still in the developmental phase as the detection technology used will depend on the type of the drug. Hence, this poses some uncertainty for the success of these devices.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/breath-analyzer-market

Further key findings from the study suggest:

·         In 2015, the fuel cell technology segment accounted for the largest share of the market at31.8%. The dominance of the segment is attributed to the popularity of this technology owing to its accuracy and user-friendly product designs.

·         The medical application segment is expected to witness the fastest growth from 2016 to 2024 owing to the rapid development of disease diagnostics, such as breath analyzers for asthma and Chronic Obstructive Pulmonary Diseases (COPD)

·         North America captured the largest market share at over half of the total revenue in 2015 and is expected to maintain its dominance throughout the forecast period. The presence of a large number of major market players, strict laws for road traffic safety, and a high adoption rate of the advanced technologies are the factors driving the market growth in this region.

·         The Asia Pacific market is expected to grow at a lucrative CAGR of around 32% during the forecast period. The existence of a large untapped market and the growing awareness regarding the commercially available and technically advanced products are some of the major drivers of the market in the region.

·         The presence of a large number of local manufacturers in the Asia Pacific region offering low-cost breath analyzers in comparison to other manufacturers based in developed countries is one of the factors expected to propel the exports from this region

·         Some key players in the Breath Analyzer Market include Dragerwerk AG & Co. KGaA, Intoximeter, Inc., Alcovisor, Quest products, Inc., Lifeloc Technologies, Akers Biosciences, Inc., MPD, Inc., AK GlobalTech Corp., Alcohol Countermeasure Systems Corp., and EnviteC-Wismar GmbH 

Read detailed report or request for sample of this research report: - http://www.grandviewresearch.com/industry-analysis/breath-analyzer-market/request

Grand View Research has segmented the Breath Analyzer Market on the basis of product, type, and geography.
Breath Analyzer Market, by Technology, 2013 – 2024 (USD Million)

·         Fuel cell Technology

·         Semiconductor sensor

·         Infrared (IR) Spectroscopy

·         Others(FAIM, Mass Spectroscopy, Smart Crystals)

Breath Analyzer Market, by Application, 2013 – 2024 (USD Million)

·         Drug Abuse Detection

·         Alcohol Detection

·         Medical Applications

Breath Analyzer Market, by region, 2013 – 2024 (USD Million)

·         North America

·         U.S. Breath Analyzer Market, by Technology Type

·         U.S. Breath Analyzer Market, by Application Type

·         Canada Breath Analyzer Market, by Technology Type

·         Canada Breath Analyzer Market, by Application Type

·         Europe

·         UK Breath Analyzer Market, by Technology Type

·         UK Breath Analyzer Market, by Application Type

·         Germany Breath Analyzer Market, by Technology Type

·         Germany Breath Analyzer Market, by Application Type 

·         Asia Pacific

·         China Breath Analyzer Market, by Technology Type

·         China Breath Analyzer Market, by Application Type

·         India Breath Analyzer Market, by Technology Type

·         India Breath Analyzer Market, by Application Type

·         Latin America

·         Brazil Breath Analyzer Market, by Technology Type

·         Brazil Breath Analyzer Market, by Application Type

·         Mexico Breath Analyzer Market, by Technology Type

·         Mexico Breath Analyzer Market, by Application Type

·         MEA

·         South Africa Breath Analyzer Market, by Technology Type

·         South Africa Breath Analyzer Market, by Application Type

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices